Request Deal Involvement

Novo Holdings, Boehringer Ingelheim and Evotec led a $33m Series A round in Centauri Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

or

Principals

CENTAURI THERAPEUTICS

target

CENTAURI THERAPEUTICS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

BOEHRINGER INGELHEIM GMBH

bidder

BOEHRINGER INGELHEIM GMBH

EVOTEC SE

bidder

EVOTEC SE

WREN CAPITAL LLP

bidder

WREN CAPITAL LLP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo Holdings, Boehringer Ingelheim and Evotec led a $33m Series A round in Centauri Therapeutics.